Intrahepatic cholangiocarcinoma (iCCA) represents a formidable malignancy originating from the epithelial lining and peribiliary glands of the intrahepatic bile ducts, ranging from the secondary ... Cholangiocarcinomas are malignant tumors that derive from cholangiocytes of small intrahepatic bile ducts or bile ductules (intrahepatic cholangiocarcinoma; ICC), or of large hilar or extrahepatic ... Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma, remains one of the most challenging malignancies to treat due to its highly ...
The New England Journal of Medicine: Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma No neoadjuvant treatment has been considered to be standard therapy for patients with resectable intrahepatic cholangiocarcinoma with high-risk factors for recurrence. The GOLP regimen ... SAN FRANCISCO -- Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA), ... EurekAlert!: Molecular and histological profiles and relevant imaging signatures of intrahepatic cholangiocarcinoma
